Rxo layoffs, on the record
Every job cut, severance charge and restructuring Rxo reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from 8,432 to 9,218 team members.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | 8,432 | As of December 31, 2023 |
| 10-K for 2024 | 9,873 | As of December 31, 2024 |
| 10-K for 2025 | 9,218 team members | December 31, 2025 |
Job cuts, severance and restructuring
Our summaryRXO took restructuring actions in 2023, which primarily comprised employee severance, and expects cumulative annualized net cost savings of about $32 million.
Word for word“This was partially offset by cost savings from restructuring actions executed in 2023, which primarily comprised employee severance.” 10-K for 2023
Our summaryRestructuring charges for 2023 were recorded, mainly severance costs, with the restructuring reserve rollforward showing severance charges of $12 million and facilities charges of $4 million.
Word for word“Restructuring costs in 2023 and 2022 were $16 million and $13 million, respectively, and primarily comprised severance costs.” 10-K for 2023
Our summaryRestructuring actions in 2022 were recorded, with severance and facility-related costs.
Word for word“Year Ended December 31, 2022 (In millions) Reserve Balance as of December 31, 2021 Charges Incurred Payments Other Reserve Balance as of December 31, 2022 Severance $ — $ 10 $ ( 2 ) $ ( 6 ) $ 2 Facilities 2 2 ( 3 ) — 1 Contract termination — 1 ( 1 ) — — Total $ 2 $ 13 $ ( 6 ) $ ( 6 ) $ 3” 10-K for 2023
Our summaryRXO engaged in restructuring actions in 2024, mainly severance and impairment of real estate operating lease assets, with restructuring costs recorded in the year.
Word for word“Restructuring costs in 2024 and 2023 were $33 million and $16 million, respectively, and primarily comprised severance and operating lease impairment costs.” 10-K for 2024
Our summaryRXO recorded restructuring costs in 2023 consisting mainly of severance and facilities costs.
Word for word“We engage in restructuring actions as part of our ongoing efforts to best use our resources and infrastructure.” 10-K for 2024
Our summaryRXO reported cost savings from restructuring actions executed in 2024 that reduced SG&A as a percentage of revenue.
Word for word“As a percentage of revenue, SG&A decreased to 14.6% in 2024 compared with 15.0% in 2023 driven primarily by cost savings from restructuring actions executed in 2024.” 10-K for 2024
Our summaryThe company recorded restructuring costs in 2025 and 2024, mainly severance costs and operating lease impairments.
Word for word“Restructuring costs in 2025 and 2024 were $38 million and $33 million, respectively, and primarily comprised severance costs and operating lease impairments.” 10-K for 2025
Our summaryThe company decided to restructure its ground and air express reporting unit and fully impaired that unit's goodwill.
Word for word“Based on the quantitative assessment performed in 2025, we recognized an impairment loss of $12 million to fully impair the goodwill of our ground and air express reporting unit as the discounted cash flows expected to be generated by the reporting unit were not sufficient to recover its carrying value.” 10-K for 2025
Our summaryThe company says it carries out restructuring actions, generally severance and impairment of real estate and equipment lease assets, to improve efficiency and profitability.
Word for word“These actions generally include severance and impairment of real estate and equipment operating lease assets, and are intended to improve our efficiency and profitability going forward.” 10-K for 2025
| Fiscal year ended | Restructuring charges | Cash paid for restructuring |
|---|---|---|
| 2021-12-31 | $2 million | $3 million |
| 2022-12-31 | $13 million | $6 million |
| 2023-12-31 | $16 million | $13 million |
| 2024-12-31 | $33 million | $20 million |
| 2025-12-31 | $38 million | $31 million |
Rxo has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Rxo’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-09. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.